Literature DB >> 20221870

The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.

Toby B Cole1, Karen Jansen, Sarah Park, Wan-Fen Li, Clement E Furlong, Lucio G Costa.   

Abstract

Most chemical exposures involve complex mixtures. The role of paraoxonase 1 (PON1) and the Q192R polymorphism in the detoxication of individual organophosphorous (OP) compounds has been well-established. The extent to which PON1 protects against a given OP is determined by its catalytic efficiency. We used a humanized transgenic mouse model of the Q192R polymorphism to demonstrate that PON1 modulates the toxicity of OP mixtures by altering the activity of another detoxication enzyme, carboxylesterase (CaE). Chlorpyrifos oxon (CPO), diazoxon (DZO), and paraoxon (PO) are potent inhibitors of CaE, both in vitro and in vivo. We hypothesized that exposure of mice to these OPs would increase their sensitivity to the CaE substrate, malaoxon (MO), and that the degree of effect would vary among PON1 genotypes if the OP was a physiologically relevant PON1 substrate. When wild-type mice were exposed dermally to CPO, DZO, or PO and then, after 4 h, to different doses of MO, the toxicity of MO was increased compared to mice that received MO alone. The potentiation of MO toxicity by CPO and DZO was higher in PON1 knockout mice, which are less able to detoxify CPO or DZO. Potentiation by CPO was higher in Q192 mice than in R192 mice due to the decreased ability of PON1(Q192) to detoxify CPO. Potentiation by DZO was similar in the Q192 and R192 mice, due to their equivalent effectiveness at detoxifying DZO. PO exposure resulted in equivalent potentiation of MO toxicity among all four genotypes. These results indicate that PON1 status modulates the ability of CaE to detoxicate OP compounds from specific mixed insecticide exposures. PON1 status can also impact the capacity to metabolize drugs or other CaE substrates following insecticide exposure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20221870      PMCID: PMC3035621          DOI: 10.1007/978-1-60761-350-3_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  63 in total

1.  Potentiation and neurotoxicity induced by certain organophosphates.

Authors:  J E CASIDA; R L BARON; M ETO; J L ENGEL
Journal:  Biochem Pharmacol       Date:  1963-01       Impact factor: 5.858

2.  Malathion A and B esterases of mouse liver--III: In vivo effect of parathion and related PNP-containing insecticides on esterase inhibition and potentiation of malathion toxicity.

Authors:  N Ramakrishna; B V Ramachandran
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

Review 3.  Current issues in organophosphate toxicology.

Authors:  Lucio G Costa
Journal:  Clin Chim Acta       Date:  2005-12-06       Impact factor: 3.786

4.  Detoxication of paraoxon by rat liver homogenate and serum carboxylesterases and A-esterases.

Authors:  J Tang; J E Chambers
Journal:  J Biochem Mol Toxicol       Date:  1999       Impact factor: 3.642

5.  Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes.

Authors:  J Tang; Y Cao; R L Rose; A A Brimfield; D Dai; J A Goldstein; E Hodgson
Journal:  Drug Metab Dispos       Date:  2001-09       Impact factor: 3.922

6.  Identification of rat and human cytochrome p450 isoforms and a rat serum esterase that metabolize the pyrethroid insecticides deltamethrin and esfenvalerate.

Authors:  Stephen J Godin; J Allen Crow; Edward J Scollon; Michael F Hughes; Michael J DeVito; Matthew K Ross
Journal:  Drug Metab Dispos       Date:  2007-06-18       Impact factor: 3.922

7.  Paraoxonase 1 (PON1) status and substrate hydrolysis.

Authors:  Rebecca J Richter; Gail P Jarvik; Clement E Furlong
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-13       Impact factor: 4.219

8.  Expression of human paraoxonase (PON1) during development.

Authors:  Toby B Cole; Rachel L Jampsa; Betsy J Walter; Tara L Arndt; Rebecca J Richter; Diana M Shih; Aaron Tward; Aldons J Lusis; Rhona M Jack; Lucio G Costa; Clement E Furlong
Journal:  Pharmacogenetics       Date:  2003-06

9.  Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning.

Authors:  Richard C Stevens; Stephanie M Suzuki; Toby B Cole; Sarah S Park; Rebecca J Richter; Clement E Furlong
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-18       Impact factor: 11.205

10.  Validation of PON1 enzyme activity assays for longitudinal studies.

Authors:  Karen Huen; Rebecca Richter; Clement Furlong; Brenda Eskenazi; Nina Holland
Journal:  Clin Chim Acta       Date:  2008-12-24       Impact factor: 3.786

View more
  6 in total

1.  Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme.

Authors:  Priyanka Bajaj; Rajan K Tripathy; Geetika Aggarwal; Abhay H Pande
Journal:  Protein Sci       Date:  2013-10-26       Impact factor: 6.725

2.  Neurobehavioral assessment of mice following repeated postnatal exposure to chlorpyrifos-oxon.

Authors:  Toby B Cole; Jenna C Fisher; Thomas M Burbacher; Lucio G Costa; Clement E Furlong
Journal:  Neurotoxicol Teratol       Date:  2012-03-07       Impact factor: 3.763

Review 3.  Organophosphorus Compounds at 80: Some Old and New Issues.

Authors:  Lucio G Costa
Journal:  Toxicol Sci       Date:  2018-03-01       Impact factor: 4.849

4.  Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma.

Authors:  Carmen Martínez; José A Molina; Hortensia Alonso-Navarro; Félix J Jiménez-Jiménez; José A G Agúndez; Elena García-Martín
Journal:  BMC Neurol       Date:  2010-08-19       Impact factor: 2.474

Review 5.  Human paraoxonase 1 as a pharmacologic agent: limitations and perspectives.

Authors:  Priyanka Bajaj; Rajan K Tripathy; Geetika Aggarwal; Abhay H Pande
Journal:  ScientificWorldJournal       Date:  2014-10-20

6.  Prenatal Exposure to Organophosphorus Pesticides and Preschool ADHD in the Norwegian Mother, Father and Child Cohort Study.

Authors:  Cherrel K Manley; Gro D Villanger; Cathrine Thomsen; Enrique Cequier; Amrit K Sakhi; Ted Reichborn-Kjennerud; Amy H Herring; Kristin R Øvergaard; Pal Zeiner; Kyle R Roell; Lawrence S Engel; Elizabeth M Kamai; Jake Thistle; Amber Hall; Heidi Aase; Stephanie M Engel
Journal:  Int J Environ Res Public Health       Date:  2022-07-02       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.